{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T20:49:18Z","timestamp":1771102158021,"version":"3.50.1"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T00:00:00Z","timestamp":1323302400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1002307","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T21:49:40Z","timestamp":1323380980000},"page":"e1002307","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Mathematical Model of Viral Kinetics In Vitro Estimates the Number of E2-CD81 Complexes Necessary for Hepatitis C Virus Entry"],"prefix":"10.1371","volume":"7","author":[{"given":"Pranesh","family":"Padmanabhan","sequence":"first","affiliation":[]},{"given":"Narendra M.","family":"Dixit","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2011,12,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","article-title":"The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.","volume":"21","author":"E Scarselli","year":"2002","journal-title":"EMBO J"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81.","volume":"282","author":"P Pileri","year":"1998","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1073\/pnas.0402253101","article-title":"CD81 is an entry coreceptor for hepatitis C virus.","volume":"101","author":"EG Cormier","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nature05654","article-title":"Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry.","volume":"446","author":"MJ Evans","year":"2007","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nature07684","article-title":"Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.","volume":"457","author":"A Ploss","year":"2009","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nm1698","article-title":"Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge.","volume":"14","author":"M Law","year":"2008","journal-title":"Nat Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nature10168","article-title":"A genetically humanized mouse model for hepatitis C virus infection.","volume":"474","author":"M Dorner","year":"2011","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1084\/jem.20090766","article-title":"Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation.","volume":"207","author":"S Fafi-Kremer","year":"2010","journal-title":"J Exp Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.23445","article-title":"Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations.","volume":"51","author":"SE Krieger","year":"2009","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"21092","DOI":"10.1074\/jbc.M110.104836","article-title":"Claudin association with CD81 defines hepatitis C virus entry.","volume":"285","author":"HJ Harris","year":"2010","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.antiviral.2010.02.003","article-title":"Development of novel therapies for hepatitis C.","volume":"86","author":"SM Lemon","year":"2010","journal-title":"Antivir Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jhep.2010.10.014","article-title":"Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies.","volume":"54","author":"MB Zeisel","year":"2011","journal-title":"J Hepatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1128\/JVI.01534-06","article-title":"The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells.","volume":"81","author":"G Koutsoudakis","year":"2007","journal-title":"J Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1128\/JVI.01748-06","article-title":"Superinfection exclusion in cells infected with hepatitis C virus.","volume":"81","author":"DM Tscherne","year":"2007","journal-title":"J Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"11082","DOI":"10.1128\/JVI.01307-06","article-title":"Persistent hepatitis C virus infection in vitro: coevolution of virus and host.","volume":"80","author":"J Zhong","year":"2006","journal-title":"J Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1128\/JVI.01134-06","article-title":"Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I.","volume":"81","author":"SB Kapadia","year":"2007","journal-title":"J Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"8316","DOI":"10.1128\/JVI.00665-08","article-title":"CD81 is a central regulator of cellular events required for hepatitis C virus infection of human hepatocytes.","volume":"82","author":"M Brazzoli","year":"2008","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1128\/JVI.02391-09","article-title":"Novel function of CD81 in controlling hepatitis C virus replication.","volume":"84","author":"YY Zhang","year":"2010","journal-title":"J Virol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1128\/JVI.01764-08","article-title":"Estimating the stoichiometry of human immunodeficiency virus entry.","volume":"83","author":"C Magnus","year":"2009","journal-title":"J Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e19941","DOI":"10.1371\/journal.pone.0019941","article-title":"Estimating the threshold surface density of gp120-CCR5 complexes necessary for HIV-1 envelope-mediated cell-cell fusion.","volume":"6","author":"SN Mulampaka","year":"2011","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.282.5386.103","article-title":"Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy.","volume":"282","author":"AU Neumann","year":"1998","journal-title":"Science"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1053\/gast.2001.24006","article-title":"Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon alpha-2a.","volume":"120","author":"S Zeuzem","year":"2001","journal-title":"Gastroenterology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1053\/jhep.2003.50218","article-title":"Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferon.","volume":"37","author":"E Herrmann","year":"2003","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/nature03153","article-title":"Modelling how ribavirin improves interferon response rates in hepatitis C virus infection.","volume":"432","author":"NM Dixit","year":"2004","journal-title":"Nature"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/hep.21657","article-title":"Triphasic decline of hepatitis C virus RNA during antiviral therapy.","volume":"46","author":"H Dahari","year":"2007","journal-title":"Hepatology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/clpt.2008.21","article-title":"Early and accurate prediction of peg-IFNs\/ribavirin therapy outcome in the individual patient with chronic hepatitis C by modeling the dynamics of the infected cells.","volume":"84","author":"P Colombatto","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"30ra32","DOI":"10.1126\/scitranslmed.3000544","article-title":"Rapid emergence of protease inhibitor resistance in hepatitis C virus.","volume":"2","author":"L Rong","year":"2010","journal-title":"Sci Transl Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1615\/CritRevImmunol.v30.i2.30","article-title":"Treatment of hepatitis C virus infection with interferon and small molecule direct antivirals: viral kinetics and modeling.","volume":"30","author":"L Rong","year":"2010","journal-title":"Crit Rev Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e1000745","DOI":"10.1371\/journal.pcbi.1000745","article-title":"A multi-variant, viral dynamic model of genotype 1 HCV to assess the in vivo evolution of protease-inhibitor resistant variants.","volume":"6","author":"BS Adiwijaya","year":"2010","journal-title":"PLoS Comput Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/hep.24272","article-title":"Second-phase hepatitis C virus RNA decline during telaprevir-based therapy increases with drug effectiveness: Implications for treatment duration.","volume":"53","author":"J Guedj","year":"2011","journal-title":"Hepatology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1073\/pnas.1100349108","article-title":"Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy.","volume":"108","author":"CS Hsu","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e1000269","DOI":"10.1371\/journal.ppat.1000269","article-title":"Genomic analysis reveals a potential role for cell cycle perturbation in HCV-mediated apoptosis of cultured hepatocytes.","volume":"5","author":"KA Walters","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.mbs.2010.02.005","article-title":"Evaluating treatment of hepatitis C for hemolytic anemia management.","volume":"225","author":"S DebRoy","year":"2010","journal-title":"Mathematical Biosciences"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e1001072","DOI":"10.1371\/journal.pcbi.1001072","article-title":"Ribavirin-induced anemia in hepatitis C virus patients undergoing combination therapy.","volume":"7","author":"SM Krishnan","year":"2011","journal-title":"PLoS Comput Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.","volume":"11","author":"T Wakita","year":"2005","journal-title":"Nat Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.1073\/pnas.0503596102","article-title":"Robust hepatitis C virus infection in vitro.","volume":"102","author":"J Zhong","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture.","volume":"309","author":"BD Lindenbach","year":"2005","journal-title":"Science"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1073\/pnas.0915130107","article-title":"Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures.","volume":"107","author":"A Ploss","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jtbi.2010.08.036","article-title":"Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.","volume":"267","author":"J Guedj","year":"2010","journal-title":"J Theor Biol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1128\/JVI.01304-06","article-title":"Mathematical modeling of subgenomic hepatitis C virus replication in Huh-7 cells.","volume":"81","author":"H Dahari","year":"2007","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1128\/JVI.02612-08","article-title":"Modeling subgenomic hepatitis C virus RNA kinetics during treatment with alpha interferon.","volume":"83","author":"H Dahari","year":"2009","journal-title":"J Virol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nrgastro.2011.49","article-title":"A new standard of care for the treatment of chronic HCV infection.","volume":"8","author":"WP Hofmann","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.bbrc.2005.01.056","article-title":"Kinetics of HCV envelope proteins' interaction with CD81 large extracellular loop.","volume":"328","author":"H Nakajima","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nbt.1790","article-title":"Label-free quantification of membrane-ligand interactions using backscattering interferometry.","volume":"29","author":"MM Baksh","year":"2011","journal-title":"Nat Biotechnol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"11331","DOI":"10.1128\/JVI.00104-06","article-title":"Diverse CD81 proteins support hepatitis C virus infection.","volume":"80","author":"M Flint","year":"2006","journal-title":"J Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-2180-9-111","article-title":"The association of CD81 with tetraspanin-enriched microdomains is not essential for hepatitis C virus entry.","volume":"9","author":"V Rocha-Perugini","year":"2009","journal-title":"BMC Microbiol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/JVI.01592-10","article-title":"Neutralizing antibody resistant hepatitis C virus cell-to-cell transmission.","volume":"85","author":"CL Brimacombe","year":"2011","journal-title":"J Virol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.1128\/JVI.00280-11","article-title":"Hepatitis C virus infection causes cell cycle arrest at the level of initiation of mitosis.","volume":"85","author":"RP Kannan","year":"2011","journal-title":"J Virol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jtbi.2008.05.031","article-title":"Modeling amantadine treatment of influenza A virus in vitro.","volume":"254","author":"CAA Beauchemin","year":"2008","journal-title":"J Theor Biol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.virol.2010.07.026","article-title":"The rate of hepatitis C virus infection initiation in vitro is directly related to particle density.","volume":"407","author":"A Sabahi","year":"2010","journal-title":"Virology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1126\/science.347575","article-title":"Models for the specific adhesion of cells to cells.","volume":"200","author":"GI Bell","year":"1978","journal-title":"Science"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1529\/biophysj.107.114439","article-title":"A coupled diffusion-kinetics model for analysis of contact-area FRAP experiment.","volume":"95","author":"J Wu","year":"2008","journal-title":"Biophys J"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.virol.2007.05.038","article-title":"Cryo-electron microscopy and three-dimensional reconstructions of hepatitis C virus particles.","volume":"367","author":"X Yu","year":"2007","journal-title":"Virology"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1371\/journal.ppat.0030063","article-title":"Electron tomography of the contact between T cells and SIV\/HIV-1: implications for viral entry.","volume":"3","author":"R Sougrat","year":"2007","journal-title":"PLoS Pathog"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1128\/JVI.78.3.1448-1455.2004","article-title":"CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.","volume":"78","author":"J Zhang","year":"2004","journal-title":"J Virol"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1002307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T16:42:57Z","timestamp":1561048977000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1002307"}},"subtitle":[],"editor":[{"given":"Roland Robert","family":"Regoes","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2011,12,8]]},"references-count":55,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,12,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1002307","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,8]]}}}